Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats

Surgery Today

Volumn 26, Issue 4, 1996, Pages 271-275

  Noguchi, Yoshikazu ^a   Nomura, Katsutoshi ^a   Yoshikawa, Takaki ^a   Fukuzawa, Kuniyasu ^a   Makino, Tatsuo ^a   Tsuburaya, Akira ^a   Matsumoto, Akihiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

insulin resistance; lipoprotein lipase; MCA sarcoma

Indexed keywords

GLUCOSE; INSULIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CACHEXIA; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MALE; METHYLCHOLANTHRENE; RATS; RATS, INBRED F344; SARCOMA, EXPERIMENTAL; TRIGLYCERIDES;

EID: 0029966598     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311587     Document Type: Article

References (23)

1. Nurjhan N, Campbell PJ, Kennedy FG (1987) Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Metabolism 35:1326-1331
2. Noguchi Y, Vydelingum NA, Younes RN, Fried SK, Brennan MF (1991) Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA. Cancer Res 51:863-869
3. Popp MB, Morrison SD, Brennan MF (1981) Total parenteral nutrition in a methylcholanthrene-induced rat sarcoma model. Cancer Treat Rep 65:137-143
4. Nilsson-Ehle P, Schotz MCA (1976) A stable radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17:536-541
5. Noguchi Y, Vydelingum NA, Brennan MF (1989) The reversal of increased gluconeogenesis in tumor-bearing rats by tumor removal and food intake. Surgery 106:423-431
6. Noguchi Y, Vydelingum NA. Brennan MF (1993) Tumor-induced alterations in hepatic malic enzyme and carnitine palmitoyl transferase activity. J Surg Res 55:357-363
7. Rohdenberg GL, Bernhard A, Krehbiel O (1919) Surgical tolerance in cancer. JAMA 72:1528-1534
8. Glicksman AS, Rawson RW (1956) Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 19:1127-1134
9. Tayek JA (1992) A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr 11:445-456
10. Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB (1982) Abnormalities in glucose and protein metabolism in non-cachectic lung cancer patients. Cancer Res 42:4815-4819
11. Yoshikawa T, Noguchi Y, Matsumoto A (1994) Effects of tumor removal and body weight loss on insulin resistance in cancer patients. Surgery 116:62-66
12. Burt ME, Aoki T, Gorschboth CM, Brennan MF (1983) Peripheral tissue metabolism in cancer-bearing man. Ann Surg 198:685-691
13. Permet J, Adrian TE, Per Jacobsson, Jorfelt L, Fruin AB, Larsson J (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 165:61-67
14. Svaninger G, Drott C, Lundholm K (1987) Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: Special reference to muscle wasting. J Natl Cancer Inst 78:943-950
15. McRussel D, Shike M, Morliss EB, Detsky AS, Shepherd FA, Feld R, Evans WK. Jeejeebhoy KN (1984) Effects of total parenteral nutrition and chemotherapy on metabolic derangement in small cell lung cancer. Cancer Res 44:1706-1711
16. Sauerwein HP, Pesola GR, Godfried MH, Levinson MR, Jeevanandam M, Brennan MF (1991) Insulin sensitivity in septic cancer-bearing patients. JJPEN 15:653-658
17. Ong JM, Kern PA (1989) The role of glucose and glycosylation in the regulation of lipoprotein lipase synthesis and secretion in rat adipocytes. J Biol Chem 264:3177-3182
18. Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:450-456
19. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldawer LL (1989) Anticachectin/tumor necrosis factor-alpha antibodies attenuated development of cancer cachexia in tumor models. FASEB J 3:1956-1962
20. Stovroff ML, Fraker DL, Norton JA (1989) Cachectin activity in the serum of cachectic, tumor-bearing rats. Arch Surg 124:94-99
21. Semb H, Peterson J, Tavanier J, Olivecrona T (1987) Multiple effects of tumor necrosis factor on lipoprotein lipase in vitro. J Biol Chem 262:8390-8394
22. Ojamaa K, Hedo JA, Roberts CT, Moncada VY, Gorden P, Ullrich G, Taylor SI (1988) Defects in human insulin receptor gene expression. Mol Endocrinol 2:242-247
23. Krett NC, Heaton JH, Gelehrter TD (1983) Insulin resistance in H-35 rat hepatoma cells is mediated by postreceptor mechanisms. Mol Cell Endocrinol 32:91-100